LAMPERTICO, PIETRO
LAMPERTICO, PIETRO
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
12 weeks ombitasvir/paritaprevir-ritonavir + ribavirin achieve high SVR rates in HCV-4 patients with advanced fibrosis
2018-07-01 E. Degasperi, A. Aghemo, S. Paolucci, R. D'Ambrosio, M. Borghi, R. Perbellini, F. Novazzi, S. De Nicola, G. Lunghi, F. Baldanti, P. Lampertico
2-year effectiveness and safety of Tenofovir in 302 NUC-naive patients with chronic hepatitis B : a multicenter european study in clinical practive
2011-01-01 P. Lampertico, R. Soffredini, M. Vigano, C. Yurdaydin, R. Idilman, G. Papatheodoridis, K. Margariti, M. Buti, R. Esteban, S. Zaltron, A. Vavassori, G. Carosi, E. Minola, M. Vinci, G. Pinzello, A. Giorgini, M. Zuin, A. Salmi, P. Del Poggio, F. De Filippi, S. Bruno, L. Pasulo, S. Fagiuoli, M. Andreoletti, A. Colli, F. Maldini, M. Milanese, A. Colombo, G. Bellati, E. Angeli, C. Magni, G. Gubertini, G. Rizzardini, M. Fasano, T. Santantonio, N. Terreni, G. Spinzi, F. Facchetti, F. Invernizzi, A. Testa
2-year effectiveness and safety of tenofovir in 302 NUC-naive patients with chronic hepatitis B: a multicenter European study in clinical practice
2012-01-01 P. Lampertico, R. Soffredini, M. Viganò, C. Yurdaydin, R. Idilman, G.V. Papatheodoridis, K. Margariti, M. Buti, R. Esteban, S. Zaltron, A. Vavassori, G. Carosi, E. Minola, M. Vinci, G. Pinzello, A.M. Giorgini, M. Zuin, A. Salmi, P. Del Poggio, F. De Filippi, S. Bruno, L. Pasulo, S. Fagiuoli, M. Andreoletti, A. Colli, F. Fumagalli Maldini, M. Milanese, A. Colombo, G.A. Bellati, E. Angeli, C.F. Magni, G.A. Gubertini, G. Rizzardini, M. Fasano, T. Santantonio, N.M. Terreni, G. Spinzi, F. Facchetti, F. Invernizzi, M. Colombo
3 years of Adefovir and Lamivudine combination therapy minimized the risk of genotypic resistance to ADV in Lam resistant patients
2007-01-01 P. Lampertico, M. Viganò, E. Manenti, M. Iavarone, G. Lunghi, E. Del Ninno, M. Colombo
3 years of Adefovir and Lamivudine combination therapy minimized the risk of genotypic resistance to ADV in Lam resistant patients
2007-01-01 P. Lampertico, M. Viganò, E. Manenti, M. Iavarone, G. Lunghi, E. Del Ninno, M. Colombo
A drug transporter gene polymorphism predicts renal tubular toxicity in patients with chronic hepatitis B on long-term adefovir and lamivudine combination
2010-04-01 M. Viganò, P. Lampertico, P. Dongiovanni, F. Facchetti, L.V.C. Valenti, R. Soffredini, S.R. Fargion, M. Colombo
A prospective study of peripheral blood alpha-fetoprotein messenger RNA in cirrhotic patients at risk of hepatocellular carcinoma
2003-11-01 M. Iavarone, P. Lampertico, G. Ronchi, E. Del Ninno, A. Zanella, M. Colombo
A response guided approach to peginterferon alfa-2a therapy based on HBsAg levels at weeks 12 and 24 improves response rates in HBeAG-negative, genotype D chronic hepatitis B patients
2011-10-01 P. Lampertico, M. Vigano, G. G. Di Costanzo, E. Sagnelli, M. Fasano, V. Di Marco, S. Boninsegna, P. Farci, S. R. Fargion, T. Giuberti, V. Rothe, L. Regep, B. Massetto, F. Facchetti, A. Testa
Acute hepatitis following assumption of a herbal remedy
2008-01-01 M. Viganò, P. Lampertico, M. Colombo
Acute kidney injury and chronic kidney disease after liver transplant: A retrospective observational study
2021-06-07 F. Fabrizi, M.F. Donato, R. Cerutti, F. Invernizzi, G. Porata, G. Frontini, F. Raffiotta, T. De Feo, C.M. Alfieri, P. Lampertico, G. Rossi, P. Messa
Add on Adefovir prevents the emergence of ADV resistance in Lamivudine-resistant patients : a 4-year study
2008-01-01 P. Lampertico, M. Viganò, E. Manenti, M. Iavarone, M. Colombo
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D
2019-01-01 P. Lampertico, M.R. Brunetto, A. Craxì, G.B. Gaeta, M. Rizzetto, A. Rozzi, M. Colombo, D. Antonio, P. Andreone, D. Antonio, G. Brancaccio, F. Bronte, L. Bruzzone, G. Caccamo, B. Caccianotti, V. Calvaruso, L. Chessa, M. Ciarallo, B. Coco, P. Colombatto, C. Cursaro, D. D'Aluisio, L. Demelia, V. DI MARCO, D. Dissegna, F. Invernizzi, I. Lenisa, T. Lembo, M. Levrero, V. Marchese, G. Mangia, A. Picciotto, S. Pierconti, D. Antonio, G. Raimondo, C. Rastelli, V. Rizzo, T. Santantonio, A. Scuteri, O. Sorbello, G. Squadrito, M. Subic, P. Toniutto, R. Vukotic
Add-on-peg-IFN improves HBSAG kinetics in patients long-term fully suppressed by nucleos(T)ide analogs
2012-01-01 P. Lampertico, F. Invernizzi, R. Soffredini, F. Facchetti, G. Lunghi, M. Viganò, M. Colombo
Adefovir added to lamivudine for hepatitis B recurrent infection in refractory B-cell chronic lymphocytic leukemia on prolonged therapy with Campath-1H
2006-04-01 A. Cortelezzi, M. Viganò, V.R. Zilioli, N.N. Fantini, M.C. Pasquini, G. Lambertenghi-Deliliers, M. Colombo, P. Lampertico
Adefovir and lamivudine combination therapy is superior to adefovir monotherapy for lamivudine-resistant patients with HBeAg-negative chronic hepatitis B
2007-01-01 P. Lampertico, A. Marzano, M. Levrero, T. Santantonio, V. Di Marco, M. Brunetto, P. Andreone, E. Sagnelli, S. Faguioli, G. Mazzellalo
Adefovir and lamivudine combination therapy is superior to adefovir monotherapy for lamivudine-resistant patients with HBeAg-negative chronic hepatitis B
2007-01-01 P. Lampertico, A. Marzano, M. Levrero, T. Santantonio, V. Di Marco, M. Brunetto, P. Andreone, E. Sagnelli, S. Fagiuoli, G. Mazzella, G. Raimondo, G.B. Gaeta, A. Ascione, T. AISF Adefovir Study Group
Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine
2005-12-01 P. Lampertico, M. Viganò, E. Manenti, M.A. Iavarone, G. Lunghi, M. Colombo
AISF position paper on HCV in immunocompromised patients
2019-01-01 A. Marzano, E. Angelucci, M. Astegiano, C. Baratelli, L. Biancone, P. Bironzo, G. Brancaccio, M.R. Brunetto, R. Bruno, P. Burra, M.G. Cabras, P. Caraceni, C. Chialà, M.G. Clemente, A. Colli, B. Daniele, E. De Gasperi, V. Di Marco, M.C. Ditto, S. Fagiuoli, C. Ferri, G.B. Gaeta, P.A. Grossi, B. Imperatrice, P. Lampertico, F.S. Macaluso, S. Madonia, M. Marignani, C. Mazzarelli, A. Mella, G. Missale, S. Parisi, L. Pasulo, M. Puoti, M. Rendina, D. Ribaldone, G. Rossi, P. Toniutto, A. Tucci, P. Vajro, M. Viganò, R. Volpes, A.L. Zignego, E.G. Giannini, L. Miele, F.P. Russo, S. Petta, S. Bonora, E. Brignardello, A. Busca, G. Cariti, F. Cavallo, M. Conforti, M. Coscia, A. Craxì, D. Curci, S. Cusinato, M. Di Maio, R.D. Valle, E. Fusaro, A. Giacardi, L. Giaccone, M. Lagget, D. Libertucci, R. Minutolo, G. Montrucchio, A. Orlando, L. Orsucci, C. Pasquina, A. Pera, C.L. Peroni, M. Pirisi, P. Racca, F. Riccardini, M. Rizzetto, M. Salizzoni, M. Salomone, G.M. Saracco, L. Scaglione, G. Torre, R. Tozzi, U. Vitolo, G. Verme
Allelic inhibition of displacement activity : a simplified one tube allele-specific PCR for evaluation of ITPA polymorphisms
2013-02-01 E. Galmozzi, F. Facchetti, E. Degasperi, A. Aghemo, P. Lampertico
Anti-TNF drugs in patients with hepatitis B or C virus infection : safety and clinical management
2012-02-01 M. Viganò, E. Degasperi, A. Aghemo, P. Lampertico, M. Colombo